Quick Answer
BIOFORCE NANOSCIENCES HOLDINGS, INC. reported Cash and Equivalents of $862.00 for fiscal year 2024.
BIOFORCE NANOSCIENCES HOLDINGS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $862.00 | +35.1% |
| 2023 | $638.00 | -13.1% |
| 2022 | $734.00 | -93.4% |
| 2021 | $11.1K | -72.1% |
| 2020 | $39.9K | -24.6% |
| 2019 | $52.9K | +80.0% |
| 2018 | $29.4K | +105.2% |
| 2017 | $14.3K | +0.0% |
| 2016 | $14.3K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $784.00 | -52.0% | -13.4% |
| June 30, 2025 | $905.00 | +35.7% | -93.4% |
| March 31, 2025 | $13.8K | +2056.1% | +1500.8% |
| December 31, 2024 | $862.00 | +35.1% | -47.3% |
| September 30, 2024 | $1.6K | +138.3% | +145.1% |
| June 30, 2024 | $667.00 | +2.0% | +4.2% |
| March 31, 2024 | $640.00 | -6.7% | +0.3% |
| December 31, 2023 | $638.00 | -13.1% | -7.0% |
- BIOFORCE NANOSCIENCES HOLDINGS, INC. showed an increase of +35.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2024 period, BIOFORCE NANOSCIENCES HOLDINGS, INC.’s cash and equivalents has declined by 94.0% (from $14.3 thousand to $862.00).
- The most recent figure is from BIOFORCE NANOSCIENCES HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: